September 24, 2016 6:15 PM ET


Company Overview of Regenxbio Inc.

Executive Profile

Luke M. Beshar CPA

Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Disclosure Committee, Regenxbio Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships


Mr. Luke M. Beshar, CPA, served as Chief Financial Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since November 20, 2007 and January 1, 2012 respectively. Mr. Beshar has 35 years of general and financial management experience. He served as a Senior Vice President of NPS Pharmaceuticals, Inc. from November 20, 2007 to January 1, 2012. He identified and evaluated strategic and corporate development opportunities, lead investor relations, assist in the ...

Corporate Headquarters

9712 Medical Center Drive
Rockville, Maryland 20850

United States

Phone: 240-552-8181
Fax: --

Board Members Memberships

Independent Director and Chairman of Audit Committee
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Disclosure Committee


Michigan State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$16,010
Total Calculated Compensation$316,550

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Alexander Macrae M.B., Ch.B, Ph.D., MRCPChief Executive Officer, President and Director
Sangamo Biosciences Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Regenxbio Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at